Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Dow
Merck
Medtronic
AstraZeneca

Last Updated: October 6, 2022

Drugs in MeSH Category Antidiarrheals


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms Barr LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 074991-001 Dec 29, 1997 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Alpharma Us Pharms LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 073187-001 Sep 15, 1992 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Perrigo LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 073243-001 Jan 21, 1992 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Teva LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 073478-001 Jun 23, 1995 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Able LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 073528-001 Nov 30, 1993 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
L Perrigo Co LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 075232-001 Jan 6, 2000 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 072741-001 Sep 18, 1991 AB RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Dow
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.